These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38063999)

  • 1. Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
    Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Joo JE; Walker R; Como J; Preston S; Chai SM; Chu YL; Meyers AL; Pope BJ; Duggan D; Fink JL; Macrae FA; Rosty C; Winship IM; Jenkins MA; Buchanan DD
    Fam Cancer; 2024 Mar; 23(1):9-21. PubMed ID: 38063999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNF43 pathogenic Germline variant in a family with colorectal cancer.
    Mikaeel RR; Young JP; Li Y; Poplawski NK; Smith E; Horsnell M; Uylaki W; Tomita Y; Townsend AR; Feng J; Zibat A; Kaulfuß S; Müller C; Yigit G; Wollnik B; Scott H; Rawlings L; Henry D; Vakulin C; Dubowsky A; Price TJ
    Clin Genet; 2022 Jan; 101(1):122-126. PubMed ID: 34541672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
    Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Martín-Morales L; Garre P; Lorca V; Cazorla M; Llovet P; Bando I; García-Barberan V; González-Morales ML; Esteban-Jurado C; de la Hoya M; Castellví-Bel S; Caldés T
    Cancer Prev Res (Phila); 2021 Feb; 14(2):185-194. PubMed ID: 33115781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.
    van Herwaarden YJ; Koggel LM; Simmer F; Vink-Börger EM; Dura P; Meijer GA; Nagengast FM; Hoogerbrugge N; Bisseling TM; Nagtegaal ID
    Histopathology; 2021 Apr; 78(5):749-758. PubMed ID: 33098683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
    Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
    Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing.
    Singh AK; Talseth-Palmer B; Xavier A; Scott RJ; Drabløs F; Sjursen W
    BMC Med Genomics; 2023 Jun; 16(1):126. PubMed ID: 37296477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
    Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
    Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on genetic predisposition to colorectal cancer and polyposis.
    Valle L; de Voer RM; Goldberg Y; Sjursen W; Försti A; Ruiz-Ponte C; Caldés T; Garré P; Olsen MF; Nordling M; Castellvi-Bel S; Hemminki K
    Mol Aspects Med; 2019 Oct; 69():10-26. PubMed ID: 30862463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic
    Alenezi WM; Fierheller CT; Revil T; Serruya C; Mes-Masson AM; Foulkes WD; Provencher D; El Haffaf Z; Ragoussis J; Tonin PN
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare germline variants in the AXIN2 gene in families with colonic polyposis and colorectal cancer.
    Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Walker R; Como J; Joo JE; Preston S; Hutchinson RA; Pope BJ; Metz A; Beard C; Purvis R; Arnold J; Vijay V; Konycheva G; Atkinson N; Parry S; Jenkins MA; Macrae FA; Rosty C; Winship IM; Buchanan DD
    Fam Cancer; 2022 Oct; 21(4):399-413. PubMed ID: 34817745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients.
    Jansen AM; Geilenkirchen MA; van Wezel T; Jagmohan-Changur SC; Ruano D; van der Klift HM; van den Akker BE; Laros JF; van Galen M; Wagner A; Letteboer TG; Gómez-García EB; Tops CM; Vasen HF; Devilee P; Hes FJ; Morreau H; Wijnen JT
    PLoS One; 2016; 11(6):e0157381. PubMed ID: 27300758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
    Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
    J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teenage-Onset Colorectal Cancers in a Digenic Cancer Predisposition Syndrome Provide Clues for the Interaction between Mismatch Repair and Polymerase δ Proofreading Deficiency in Tumorigenesis.
    Schamschula E; Kinzel M; Wernstedt A; Oberhuber K; Gottschling H; Schnaiter S; Friedrichs N; Merkelbach-Bruse S; Zschocke J; Gallon R; Wimmer K
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
    Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
    Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of germline variants in cancer-associated genes in young adults with colorectal cancer.
    Mikaeel RR; Young JP; Li Y; Smith E; Horsnell M; Uylaki W; Tapia Rico G; Poplawski NK; Hardingham JE; Tomita Y; Townsend AR; Feng J; Zibat A; Kaulfuß S; Müller C; Yigit G; Wollnik B; Price TJ
    Genes Chromosomes Cancer; 2022 Feb; 61(2):105-113. PubMed ID: 34761457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis.
    Mur P; Jemth AS; Bevc L; Amaral N; Navarro M; Valdés-Mas R; Pons T; Aiza G; Urioste M; Valencia A; Lázaro C; Moreno V; Puente XS; Stenmark P; Warpman-Berglund U; Capellá G; Helleday T; Valle L
    Hum Mutat; 2018 Sep; 39(9):1214-1225. PubMed ID: 29900613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
    Sorscher S; Ansley K; Delaney SD; Ramkissoon S
    Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.